Central nervous system candidiasis in preterm infants: limited value of biochemical markers for diagnosis

P C Ng1, C H Lee, T F Fok

  • 1Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories. pakcheungng@cuhk.edu.hk

Insights

Biochemical markers often fail to detect rare central nervous system (CNS) candidiasis in preterm infants. Early diagnosis of this serious fungal infection requires clinical suspicion, not just lab tests.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Mycology

Background:

  • Central nervous system (CNS) candidiasis is a rare but life-threatening fungal infection in preterm infants.
  • Early diagnosis is crucial for effective treatment and improved outcomes.

Observation:

  • Two cases of isolated CNS candidiasis in preterm infants were diagnosed over six years.
  • Standard biochemical infection markers were not useful for early identification.

Findings:

  • The localized fungal infection likely originated from a low-level, transient bloodstream invasion.
  • Absence of fungemia or systemic signs prevented the activation of typical inflammatory markers.

Implications:

  • Clinicians must recognize the limitations of biochemical markers in diagnosing CNS candidiasis in neonates.
  • Prompt clinical evaluation and consideration of fungal infection are essential to avoid diagnostic delays.